IN VITRO MODELING OF HUMAN ALVEOLAR MACROPHAGE SMOKE EXPOSURE: ENHANCED INFLAMMATION AND IMPAIRED FUNCTION
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 34 (9) , 599-629
Abstract
Pulmonary macrophages (MØs) are essential for clearance of inhaled particles, innate immunity, and lung tissue maintenance. However, the products of activated MØs have also been implicated in inflammation and tissue destruction, including in chronic obstructive pulmonary disease (COPD). Primary human alveolar macrophages (AMs) are available in limited numbers via bronchoalveolar lavage (BAL) or sputum induction, and BAL macrophages are not commonly available to all researchers. A readily available, plentiful, but representative surrogate for AMs would advance understanding of the contribution of macrophages to lung pathophysiology. Herein the authors describe a method for the in vitro derivation of AM-like cells using primary human peripheral blood monocytes differentiated in suspension with granulocyte-macrophage colony-stimulating factor (GM-CSF). The method produces a cell population with a consistent and stable phenotype. Flow cytometry reveals that GM-CSF–derived macrophages (GM-MØs) express lineage markers, immunoglobulin gamma (Fcγ) receptors, adhesion molecules, antigen presentation coreceptors, and scavenger receptors akin to AMs. Functionally, cigarette smoke activates extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, enhances interleukin 8 (IL8) production from GM-MØs and inhibits phagocytosis, phenotypes previously described for smokers' AMs. Global transcriptional profiling revealed significant overlap in regulated genes between smokers' AMs and GM-MØs treated with cigarette smoke preparations in vitro.Keywords
This publication has 59 references indexed in Scilit:
- Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometryRespiratory Research, 2008
- The Prolonged Life-Span of Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokersClinical and Experimental Immunology, 2006
- Upregulation of CD40, CD80, CD83 or CD86 on Alveolar Macrophages After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPDEuropean Respiratory Journal, 2005
- Alveolar Macrophages as Orchestrators of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
- Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cellsImmunology & Cell Biology, 2003
- Flow cytometric assay of lung macrophage uptake of environmental particulatesCytometry, 1995
- Pulmonary macrophagesEuropean Respiratory Journal, 1994
- Interleukin 3: From colony-stimulating factor to pluripotent immunoregulatory cytokineInternational Journal of Immunopharmacology, 1992